The Pharmaceutical Industry Could Be More Transparent: GSK CEO

The transcript discusses the public's perception of pharmaceutical companies, highlighting criticisms about profit-making and image issues. It emphasizes the industry's significant role in global health and the need for collaboration. The tension between healthcare access and corporate profits is explored, along with the industry's historical challenges. The speaker suggests improving transparency, pricing responsibility, and partnerships with governments to enhance healthcare access and industry practices. The importance of innovation in addressing diseases like cancer and Alzheimer's is also highlighted.

What is one of the main public concerns about pharmaceutical companies?

• Their investment in research

• Their profit-making and image

• Their collaboration with governments

• Their contribution to global healthcare

What is the perceived tension in the pharmaceutical industry?

• Between research and development

• Between profit and access to healthcare

• Between transparency and secrecy

• Between collaboration and competition

How has the pharmaceutical industry tried to improve its image?

• By reducing profits

• By increasing transparency and collaboration

• By avoiding all criticisms

• By focusing only on developing countries

What is a key responsibility of the pharmaceutical industry according to the transcript?

• To protect health and find new solutions

• To maximize profits

• To focus solely on developed countries

• To reduce research investments

What does the industry need to do to address future health challenges?

• Ignore public perception

• Continue fighting and investing in research

• Focus only on current diseases

• Stop investing in research